Treatment and Investigations for Meniere's Disease
For patients with Meniere's disease, first-line treatment should include lifestyle modifications (low-sodium diet, limiting alcohol and caffeine), diuretics, and/or betahistine, with progression to intratympanic steroids for those not responsive to conservative treatment. 1, 2
Diagnostic Evaluation
Required Investigations
Detailed history focusing on:
- Vertigo characteristics (spontaneous attacks lasting 20 minutes to 12 hours)
- Fluctuating hearing symptoms
- Tinnitus and aural fullness 1
Audiometric testing to document fluctuating low- to mid-frequency sensorineural hearing loss 1
Vestibular function tests:
MRI of brain to:
- Rule out other causes (e.g., vestibular schwannoma)
- Potentially visualize endolymphatic hydrops 1
Treatment Algorithm
1. First-Line Treatment (Conservative Management)
Dietary and Lifestyle Modifications:
Pharmacological Options:
2. Second-Line Treatment
- Intratympanic steroids for patients with active Meniere's disease not responsive to noninvasive treatment 2, 1
3. Third-Line Treatment (Based on Hearing Status)
For patients with usable hearing:
For patients with non-usable hearing:
Important Clinical Considerations
Effectiveness of Treatments
Positive pressure therapy should NOT be prescribed as it has been shown to be ineffective 2
Vestibular rehabilitation/physical therapy should NOT be recommended for managing acute vertigo attacks but may be beneficial during the intercritic period 2, 5
Betahistine and diuretics have shown benefit in observational studies, though evidence quality is moderate 2
Treatment Monitoring
- Regular audiometric testing to track hearing loss progression
- Document changes in vertigo frequency and severity
- Assess impact on quality of life 1
Cautions and Pitfalls
Diagnostic challenges: Meniere's disease can be confused with vestibular migraine, BPPV, or vestibular neuritis - careful attention to symptom patterns is essential 1
Bilateral disease: Consider more conservative approaches as 10-25% of cases may become bilateral over time 2
Sodium restriction risks: While recommended, monitor for hyponatremia, especially in elderly patients or those with comorbidities 2
Intratympanic gentamicin risks: Can cause hearing loss; low-dose protocols are now preferred to balance vertigo control with hearing preservation 6
Patient expectations: The disease course can be unpredictable with symptoms that may naturally fluctuate, making treatment efficacy assessment challenging 2, 1
The treatment approach should follow a stepwise progression, starting with conservative measures and advancing to more invasive options only when symptoms remain uncontrolled. Quality of life should be a primary consideration in treatment decisions, as the unpredictable nature of attacks can cause significant anxiety and social isolation 1.